Cargando…

Heterologous T cell immunity in severe hepatitis C virus infection

Hepatitis C virus (HCV) can cause liver disease of variable severity. Expansion of preexisting memory CD8 T cells by cross-reactivity with a new heterologous virus infection has been shown in mice to shape the repertoire of the primary response and to influence virus-related immunopathology (Selin,...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbani, Simona, Amadei, Barbara, Fisicaro, Paola, Pilli, Massimo, Missale, Gabriele, Bertoletti, Antonio, Ferrari, Carlo
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212827/
https://www.ncbi.nlm.nih.gov/pubmed/15753202
http://dx.doi.org/10.1084/jem.20041058
_version_ 1782148767322996736
author Urbani, Simona
Amadei, Barbara
Fisicaro, Paola
Pilli, Massimo
Missale, Gabriele
Bertoletti, Antonio
Ferrari, Carlo
author_facet Urbani, Simona
Amadei, Barbara
Fisicaro, Paola
Pilli, Massimo
Missale, Gabriele
Bertoletti, Antonio
Ferrari, Carlo
author_sort Urbani, Simona
collection PubMed
description Hepatitis C virus (HCV) can cause liver disease of variable severity. Expansion of preexisting memory CD8 T cells by cross-reactivity with a new heterologous virus infection has been shown in mice to shape the repertoire of the primary response and to influence virus-related immunopathology (Selin, L.K. 2004. Immunity. 20:5–16). To determine whether this mechanism can influence the course of HCV infection, we analyzed the features of the HCV-specific CD8 T cell response in eight patients with acute HCV infection, two of whom had a particularly severe illness. Patients with severe hepatitis, but not those with mild disease, showed an extremely vigorous CD8 T cell response narrowly focused on a single epitope (NS3 1073–1081), which cross-reacted with an influenza neuraminidase sequence. Our results suggest that CD8 T cell cross-reactivity influences the severity of the HCV-associated liver pathology and depicts a model of disease induction that may apply to different viral infections.
format Text
id pubmed-2212827
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-22128272008-03-11 Heterologous T cell immunity in severe hepatitis C virus infection Urbani, Simona Amadei, Barbara Fisicaro, Paola Pilli, Massimo Missale, Gabriele Bertoletti, Antonio Ferrari, Carlo J Exp Med Brief Definitive Report Hepatitis C virus (HCV) can cause liver disease of variable severity. Expansion of preexisting memory CD8 T cells by cross-reactivity with a new heterologous virus infection has been shown in mice to shape the repertoire of the primary response and to influence virus-related immunopathology (Selin, L.K. 2004. Immunity. 20:5–16). To determine whether this mechanism can influence the course of HCV infection, we analyzed the features of the HCV-specific CD8 T cell response in eight patients with acute HCV infection, two of whom had a particularly severe illness. Patients with severe hepatitis, but not those with mild disease, showed an extremely vigorous CD8 T cell response narrowly focused on a single epitope (NS3 1073–1081), which cross-reacted with an influenza neuraminidase sequence. Our results suggest that CD8 T cell cross-reactivity influences the severity of the HCV-associated liver pathology and depicts a model of disease induction that may apply to different viral infections. The Rockefeller University Press 2005-03-07 /pmc/articles/PMC2212827/ /pubmed/15753202 http://dx.doi.org/10.1084/jem.20041058 Text en Copyright © 2005, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Brief Definitive Report
Urbani, Simona
Amadei, Barbara
Fisicaro, Paola
Pilli, Massimo
Missale, Gabriele
Bertoletti, Antonio
Ferrari, Carlo
Heterologous T cell immunity in severe hepatitis C virus infection
title Heterologous T cell immunity in severe hepatitis C virus infection
title_full Heterologous T cell immunity in severe hepatitis C virus infection
title_fullStr Heterologous T cell immunity in severe hepatitis C virus infection
title_full_unstemmed Heterologous T cell immunity in severe hepatitis C virus infection
title_short Heterologous T cell immunity in severe hepatitis C virus infection
title_sort heterologous t cell immunity in severe hepatitis c virus infection
topic Brief Definitive Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212827/
https://www.ncbi.nlm.nih.gov/pubmed/15753202
http://dx.doi.org/10.1084/jem.20041058
work_keys_str_mv AT urbanisimona heterologoustcellimmunityinseverehepatitiscvirusinfection
AT amadeibarbara heterologoustcellimmunityinseverehepatitiscvirusinfection
AT fisicaropaola heterologoustcellimmunityinseverehepatitiscvirusinfection
AT pillimassimo heterologoustcellimmunityinseverehepatitiscvirusinfection
AT missalegabriele heterologoustcellimmunityinseverehepatitiscvirusinfection
AT bertolettiantonio heterologoustcellimmunityinseverehepatitiscvirusinfection
AT ferraricarlo heterologoustcellimmunityinseverehepatitiscvirusinfection